Physician

Sami Adnan Abbasi, DO

According to 2025 Medicare claims, Sami Abbasi, DO (NPI: 1083778690) practices dermatology in the Detroit-Dearborn-Livonia, MI market, with the plurality of this provider's patient population coming from Wayne, MI. This provider's primary affiliated billing organization is SAMI ABBASI DO PLLC (NPI: 1497079230; TIN: 271993722) and primary practice location at 48183-1665.

Abbasi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 993 traditional Medicare patients, billed 6,307 HCPCS/CPT codes, and received $481,130 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,570 prescription claims across 622 beneficiaries totaling $881,464 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 171 records totaling $3,598. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $157,168 to $481,130. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $205,365 to $881,464. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$241K$481K2015 Medicare payment: $157,168 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $204,544 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $206,729 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $232,185 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $239,484 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $199,115 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $281,484 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $387,230 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $447,220 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $481,130 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155872,930$157,168
20167624,007$204,544
20178184,318$206,729
20189224,624$232,185
20199594,548$239,484
20208013,547$199,115
20219464,587$281,484
20229415,528$387,230
20238746,004$447,220
20249936,307$481,130

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$517K$1.0M2015 Drug cost: $205,365 (USD; Tot_Drug_Cst)2016 Drug cost: $201,614 (USD; Tot_Drug_Cst)2017 Drug cost: $398,573 (USD; Tot_Drug_Cst)2018 Drug cost: $508,871 (USD; Tot_Drug_Cst)2019 Drug cost: $588,930 (USD; Tot_Drug_Cst)2020 Drug cost: $421,976 (USD; Tot_Drug_Cst)2021 Drug cost: $710,284 (USD; Tot_Drug_Cst)2022 Drug cost: $748,005 (USD; Tot_Drug_Cst)2023 Drug cost: $1,033,251 (USD; Tot_Drug_Cst)2024 Drug cost: $881,464 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153791,014$205,365
2016415959$201,614
20174331,007$398,573
20185851,415$508,871
20195251,194$588,930
20205371,255$421,976
20215931,432$710,284
20225521,317$748,005
20235761,374$1,033,251
20246221,570$881,464

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths286390$85
11102Biopsy of related skin growth, first growth233265$69
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more581791$67
17000Destruction of precancer skin growth, 1 growth305445$41
17003Destruction of precancer skin growth, 2-14 growths2181,145$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab16448$183,804
TremfyaGuselkumab12672$158,996
Dupixent PenDupilumab17574$73,397
OtezlaApremilast12360$56,806
CiclopiroxCiclopirox2016,468$7,719

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.171$3,598Lumenis BE inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Sami Adnan Abbasi, DO?

Tedicare shows public-source Medicare data for Sami Adnan Abbasi, DO (NPI 1083778690), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sami Adnan Abbasi, DO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sami Adnan Abbasi, DO?

Sami Adnan Abbasi, DO is linked to SAMI ABBASI DO PLLC (billing NPI 1497079230) in the available physician profile data.

Does Sami Adnan Abbasi, DO have Open Payments data?

Sami Adnan Abbasi, DO has 171 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.